Evaxion A/S (NASDAQ: EVAX) will present new preclinical data for its EVX-04 therapeutic vaccine targeting acute myeloid leukemia at the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE